Close menu

 

Member of Lyonbiopole

 

GeNeuro develops treatments against neurodegenerative and autoimmune diseases by neutralizing harmful Human Endogenous Retrovirus proteins (HERVs). 8% of human DNA possesses a viral origin, left by the viruses that infected our ancestors.

 

Strategic application domain: Human Medicine

Application market: Neurology & Mental Health Disorders

Type of activity: Therapeutics, Pharma or Biotech

Technologies: Antibodies - Protein - Peptide

Created on feb. 18th, 2009 - 8 employees

 

Address

60 avenue de Rockefeller 69008 Lyon

 

Contacts

You must be logged in and a member of Lyonbiopôle to see the contacts.